[#item_full_content]
Author:
[#item_full_content]
Banks are reporting a ten-fold surge in digital scams, cybersecurity firm BioCatch says
[#item_full_content]Banks are under pressure to kick criminals off their platforms and compensate more victims as regulators…
Opna Bio Announces 2024 ASH Presentations Highlighting Interim Data from Phase 1 Combo Study of BET Inhibitor OPN-2853 with Ruxolitinib in Myelofibrosis, and Promising Preclinical Data with EP300/CBP Bromodomain Inhibitor OPN-6602 in Multiple Myeloma
[#item_full_content]SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development…